Related Experiment Video
Updated: Oct 16, 2025

Intracarotid Cancer Cell Injection to Produce Mouse Models of Brain Metastasis
Published on: February 8, 2017
Brain Metastases and Microenvironment
1Research Institute for Medicines (iMed.ULisboa), Faculdade de Farmácia, Universidade de Lisboa, Lisbon, Portugal. abrito@ff.ulisboa.pt.
Abstract:
The formidable advances in cancer treatment have led to remarkable improvements in patient's survival, so that the major concern shifted from primary tumors to metastatic disease. Brain metastases represent a life-threatening condition with a poor prognosis due to the lack of reliable biomarkers that preclude their timely identification and to the scarce therapeutic possibilities considering that the blood-brain barrier limits the access of most of the drugs to the brain and surgical resection is discouraged in cases of multiple metastases. Moreover, brain metastases have been scarcely investigated, which precludes a comprehensive understanding of the determinants and players, as well as of the complex cross-talk and signaling pathways involved. This chapter summarizes the impressive numbers about cancer and brain metastases and the estimates of progression in the years to come. It also gathers together the relevant concepts about the metastatic cascade, focusing in the extravasation step across the microvascular endothelium that leads to the formation of brain metastases. Moreover, it comprehensively explores the brain tumor microenvironment, detailing on the pre-metastatic niches and their relevance for tumor cell development in the target organ. Additionally, the cellular and acellular components, as well as their interplay, activation status, and acquired phenotypes, are addressed. Collectively, by bringing together historical concepts and state-of-the-art knowledge, this chapter shall contribute to a better understanding of the brain metastasization process, essential for the development of novel approaches to improve patients' life quality and expectancy.
Insights
Brain metastases are a major concern in cancer survival, yet remain poorly understood. This review details the metastatic cascade and brain tumor microenvironment to improve future treatments.
Area of Science:
- Oncology
- Cancer Metastasis Research
- Neuro-oncology
Background:
- Cancer survival has improved, shifting focus to metastatic disease, particularly brain metastases.
- Brain metastases present a significant challenge due to poor prognosis, limited biomarkers, and drug delivery issues across the blood-brain barrier.
- The complex biology of brain metastases, including signaling pathways and cellular interactions, is not well understood.
Purpose of the Study:
- To summarize current knowledge on cancer and brain metastases.
- To elucidate the metastatic cascade, focusing on extravasation into the brain.
- To explore the brain tumor microenvironment and its role in metastasis development.
Main Methods:
- Literature review and synthesis of existing research on cancer metastasis.
- Analysis of the metastatic cascade, specifically the extravasation process.
- Detailed examination of the brain tumor microenvironment, including cellular and acellular components.
Main Results:
- Cancer patients increasingly face challenges from metastatic disease, especially brain metastases.
- The extravasation step is critical for brain metastasis formation.
- The brain tumor microenvironment, including pre-metastatic niches, plays a crucial role in supporting tumor cell development.
Conclusions:
- A comprehensive understanding of brain metastasis is essential for developing new therapeutic strategies.
- Further research into the determinants and signaling pathways involved in brain metastasis is needed.
- Improving the understanding of brain metastasis biology can enhance patient quality of life and expectancy.
More Related Videos
Related Concept Videos
The Tumor Microenvironment
Metastasis
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Mitogens and the Cell Cycle

